Is Senseonics Holdings, Inc. Common Stock (SENS) overvalued? · rev $22.5M
Senseonics Holdings, Inc. Common Stock (SENS) is a medical devices company listed on NASDAQ.
This page asks whether Senseonics Holdings, Inc. Common Stock (SENS) looks expensive on cached numbers — not a short thesis.
Latest reported SENS revenue for 2024-12-31 was $22.5M. Net income was -$78.6M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. SENS currently screens at market cap $377.4M.
SENS currently screens at market cap $377.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SENS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SENS stock page for the full model, not this heading.
Not investment advice.